Cellular and molecular basis of estrogen's neuroprotection: Potential relevance for Alzheimer's disease

Molecular Neurobiology

Volumn 17, Issue 1-3, 1998, Pages 73-86

  Inestrosa, Nibaldo C ^a   Marzolo, María Paz ^a   Bonnefont, Andrea B ^a  

^a NONE

Author keywords

Alzheimer's disease; Apolipoprotein E; APP processing; Cholinergic neurons; Estrogen; Neuroprotection; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; ESTROGEN;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLINERGIC NERVE CELL; DRUG MECHANISM; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HUMAN; NEUROPROTECTION; OXIDATIVE STRESS; PROTEIN EXPRESSION;

EID: 0032420997     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02802025     Document Type: Article

References (124)

1. Alvarez J., Moreno R. D., and Inestrosa N. C. (1995) Mitosis of Schwan cells and demyelination are induced by the amyloid precursor protein and other protease inhibitors in the rat sciatic nerve. Eur. J. Neurosci. 7, 152-159.
2. Bachman D. K., Wolf P. A., and Linn R. (1992) Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham study. Neurology 42, 115-119.
3. Banker G. A. (1980) Trophic interactions between astroglial cells and hippocampal neurons in culture. Science 209, 809-810.
4. Behl C., Davis J., Lesley R., and Schunbert D. (1994) Hydrogen peroxide mediates amyloid-beta protein toxicity. Cell 77, 817-827.
5. Behl C., Davis J., Cole G. M., and Schubert D. (1992) Vitamin E protects nerve cells from amyloid-beta protein toxicity. Biochem. Biophys. Res. Commun. 186, 944-990.
6. Behl C., Thomas S., Lezoulac'h F., Post A., Widmann M., Newton C. J., and Holsboer F. (1997) Neuroprotection against oxidative stress by estrogen: structure-activity relationship. Mol. Pharmacol. 51, 535-541.
7. Behl C. W., Widman M. T., and Holsboer F. (1995) 17-beta-estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216, 473-478.
8. Bellosta S., Nathan B. P., Orth M., Dong L. M., Mahley R. W., and Pitas R. E. (1995) Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270, 27,063-27,071.
9. Bertrand P., Poirier J., Tomiichiro O., Finch. C. E., and Pasinetti G. M. (1995) Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clustering) in Alzheimer disease. Mol. Brain Res. 33, 174-178.
10. Birge S. J. (1996) Is there a role of estrogen replacement therapy in the prevention and treatment of dementia? J. Amer. Geriat. Soc. 44, 865-870.
11. Blass J. P. and Poirier J. (1996) Pathology of the Alzheimer syndrome, in Clinical Diagnosis and Management of Alzheimer's Disease, (Gauthier S., ed.) Martin Dunitz Press, London. pp. 17-31.
12. Boyles J. K., Zoellner C. D., Anderson L. J., Kosick L. M., Pitas R. E., Hui D. Y., Mahley R. W., Gebicke-Haerter P. J., Ignatius M. J., and Shooter E. M. (1989) A role for apolipoprotein E, apolipoprotein A-1, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelinization of the rat sciatic nerve. J. Clin. Invest. 83, 1015-1031.
13. Braughler J. M. and Pregenzer J. F. (1989) The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxy radicals. Free Rad. Biol. Med. 7, 125-130.
14. Breedlove S. M. (1992) Sexual dimorphism in the vertebrate nervous system. J. Neurosci. 12, 4133-4142.
15. Breen K., Bruce M., and Anderton B. H. (1991) Beta-amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion. J. Neurosci. Res. 28, 90-100.
16. Bronfman F. C., Soto C., Tapia L., Tapia V., and Inestrosa N. C. (1996) Extracellular matrix regulates the amount of the beta-amyloid precursor protein and its amyloidogenic fragments. J. Cell. Physiol. 166, 360-369.
17. Brown R. H. (1995) Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 80, 687-695.
18. Bu G., Maksymovitch E. A., Nerbonne J. M., and Schwartz A. L. (1994) Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J. Biol. Chem. 269, 18,521-18,528.
19. Carpenter M. K., Hassinger T. D., Whalen L. R., and Kater S. B. (1994) CNS white matter can be altered to support neuronal outgrowth. J. Neurosci. Res. 37, 1-14.
20. Chen M. and Yankner B. A. (1991) An antibody to beta-amyloid and the amyloid precursor inhibits cell-substratum adhesion in many mammalian cell types. Neurosci. Lett. 125, 223-226.
21. Christie R. H., Chung H., Rebeck G. W., Strickland D., and Hyman B. (1996) Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55, 491-498.
22. Copain A., Koh J. Y., and Cotman C. W. (1991) Beta-amyloid increases neuronal susceptibility to injury by glucose deprivation. NeuroReport 2, 763-765.
23. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., and Pericak-Vance M. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261, 921-923.
24. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Jr., Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E., and Tanzi R. E. (1995) Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 45, 1323-1328.
25. Coyle J. T. and Puttfarken P. (1993) Oxidative stress, glutamate and neurodegenerative disorders. Science 262, 689-695.
26. Das S. K., Taylor J. A., Korach K. S., Paria B. C., Dey S. K., and Lubahn D. B. (1997) Estrogenic responses in estrogen-α deficient mice reveal a distinct estrogen signaling pathway. Proc. Natl. Acad. Sci. USA 94, 12,786-12,791.
27. Dickson R. B., Mc Manaway M. E., and Lippman M. E. (1986) Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science 232, 1540-1543.
28. Drouva S. V., Gorenne I., Laplante E., Rerat E., Enjalbert A., and Kordon C. (1990) Estradiol modulates protein kinase C activity in the rat pituitary in vivo and in vitro. Endocrinology 126, 536-544.
29. Elkabes S., DiCicco-Bloom E. M., and Black I. B. (1996) Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci. 16, 2508-2521.
30. Elshourbagy N. A., Liao W. S., Mahley R. W., and Taylor J. M. (1985) Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. USA 82, 203-207.
31. Evans R. M. (1988) The steroid and thyroid receptor superfamily. Science 240, 889-895.
32. Fillit H., Weinreb H., Cholst I., Luine V., Mc Ewen B., Amador R., and Zabriskie J. (1986). Observation in a preliminary open trial of estradiol therapy for senile dementia: Alzheimer's type. Psychoneuroendocrinology 11, 337-345.
33. Fisher W., Gage F., and Bjorklund A. (1989) Degenerative changes in forebrain cholinergic nuclei correlate with cognitive impairments in aged rats. Eur. J. Neurosci. 1, 34-35.
34. García-Segura L. M., Chowen J. A., Párducz, A., and Naftolin F. (1994) Gonadal hormones as promoters of structural synaptic plasticity: cellular mechanisms. Prog. Neurobiol. 44, 279-307.
35. Gibbs R. B. (1994) Estrogen and nerve growth factor related systems in brain. Ann. NY Acad. Sci. 743, 165-199.
36. Gibbs R. B. (1997) Effects of estrogen on basal forebrain cholinergic neurons vary as a function of dose and duration of treatment. Brain Res. 757, 10-16.
37. Haass C. and Selkoe D. J. (1993) Cellular processing of beta-amyloid precursor protein and the genesis of amyloid-beta-peptide. Cell 75, 1039-1042.
38. Hall E. D., Pazara K. E., and Linseman K. L. Sex differences in postischemic neuronal necrosis in gerbils. J. Cereb. Blood Flow Metab. 11, 292-298.
39. Henderson V., Paganini-Hill A. A., Emanuel C. K., Dunn M. E., and Buckwelker J. G. (1994) Estrogen replacement therapy in older women: comparison between Alzheimer's disease cases and nondemented controls. Arch. Neurol. 51, 896-899.
40. Honjo H., Ogino Y., Naitoh K., Urabe M., Kitawaki J., Yasuda J., Yamamoto T., Ishihara S., Okada H., Yonezawa T., Hayashi K., and Nambara T. (1989) In vivo effects by estrone sulfate on the central nervous system: senile dementia (Alzheimer's type). J. Steroid Biochem. 34, 521-525.
41. Honjo J., Tamura T., Matsumoto Y., Kawata M., Ogino Y., Tamaka K., Yamamoto T., Ueda S., and Okado H. (1992) Estrogen as a growth factor to central nervous cells. J. Steroid. Biochem. 41, 633-635.
42. Ishiguro M., Imai Y., and Kohsaka S. (1995) Expression and distribution of low density lipoprotein receptor-related protein mRNA in the rat central nervous system. Brain Res. Mol. Brain Res. 33, 37-46.
43. Jaffe A. B., Torand-Allerand C. D., Greengard P., and Gandy S. E. (1994) Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J. Biol. Chem. 269, 13,065-13,068.
44. Jing S., Tapley P., and Barbacid M. (1992) Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron 9, 1067-1079.
45. Jones K. J. (1988) Steroid hormones and neurotrophism: relationship to nerve injury. Metab. Brain. Dis. 3, 1-18.
46. Kaplan D. R., Martin-Zanca D., and Parada L. F. (1991a) Tyrosine phosphorylation and tyrosine kinase activity of the trk-proto-oncogene produced by NGF. Nature 350, 158-160.
47. Kaplan D. R., Hempstead B., Martin-Zanca D., Chao M. V., and Parada L. F. (1991b) The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 252, 554-558.
48. Kibbey M. C., Jucker M., Weeks B. S., Neve R. L., Van Norstrand W. E., and Kleinman H. K. (1993) Beta-amyloid precursor protein binds to neurite-promoting IKVAV site of Laminin. Proc. Natl. Acad. Sci. USA 90, 10,150-10,153.
49. Kim D. H., Iijima H., Goto K., Sakai J., Ishii H., Kim H. J., Suzuki H., Kondo H., Saeki S., and Yamamoto T. (1996) Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J. Biol. Chem. 271, 8373-80.
50. Koh J. Y., Yang L. L., and Cotman C. W. (1990) Beta-amyloid protein increases the vulnerability of culture cortical neurons to excitotoxic damage. Brain. Res. 533, 315-320.
51. Korach K. S. (1994) Insights from the study of animals lacking functional estrogen receptor. Science 266, 1524-1527.
52. Kuiper G. G., Enmark E., Pelto-Huikko M., Nilsson S., and Gustafsson J. A. (1996) Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93, 5925-5930.
53. Kushwaha R. S., Foster D. M., Barrett K. D., Carey K. D., and Bernard M.G. (1991) Metabolic regulation of plasma apolipoprotein E by estrogen and progesterone in the baboon (Papio sp.). Metabolism 40, 93-100.
54. Landers J. P. and Spelsberg T. C. (1992) New concepts in steroid hormone action: transcription factors, proto-oncogenes, and the cascade model for steroid regulation of gene expression. Crit. Rev. Eukaryotic Gene Expression 2, 19-63.
55. Lobo R. A. (1995) Benefits and risks of estrogen replacement therapy. Am. J. Obstet. Gynecol. 173, 982-989.
56. Lockhart B. P., Benicourt C., Junien J.-L., and Privat A. (1994) Inhibition of free radical formation fail to alternate direct beta-amyloid peptide-mediated neurotoxicity in rat hippocampal cultures. J. Neurosci. Res. 39, 494-505.
57. Lubahn D. B., Moyer J. S., Golding T. S., Course J. F., Korach K. S., and Smities O. (1993) Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. USA 90, 11162-11166.
58. Luine V. N. (1992) Estradiol increases choline acetyl transferase activity in specific basal forebrain nuclei and projection area of female rats. Exp. Neurol. 89, 484-490.
59. Lustig R. H. (1994) An in vitro model for the effects of estrogen on neurons employing estrogen receptor-transfected PC12 cells. J. Neurosci. 14, 3945-3957.
60. Mahley R. W. (1989) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
61. Mahley R. W. (1996) Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease. Isr. J. Med. Sci. 32, 414-29.
62. 2[female]-independent lipid-stimulated kinase in the rabbit corpus luteum of pseudopregnancy. Identification of luteal estrogen-modulated lipid-stimulated kinase as protein kinase C delta. J. Biol. Chem. 267, 17,061-17,068.
63. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., and Rose A. D. (1995) Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136, 107-122.
64. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. E. (1992) Beta-amyloid peptide destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
65. Mc Ewen B. S. (1981) Endocrine effects on the brain and their relationship to behavior, in Basic Neurochemistry, 3rd ed. Little Crown & Co., Boston pp.775-799.
66. Mc Ewen B. S. (1988) Steroid hormones in the brain: linking nature and nurture. Neurochem. Res. 13, 663-669.
67. Mc Ewen B. S., Coirini H., Danielsson A., Frankfurt M., Gould E., Mendelson S., Segarra A., and Wooley C. (1991) Steroid and thyroid hormones modulate a changing brain. J. Steroid Biochem. Mol. Biol. 40, 1-14.
68. Mc Ewen B. S., de Kloet E. R., and Rostene W. (1986) Adrenal steroid receptors and actions in the nervous system. Physiol. Rev. 66, 1121-1188.
69. Mc Ewen B. S., Gerlach J. L., and Micco D. J. (1975) Putative glucocorticoid receptors in hippocampus and other regions of the rat brain, in The Hippocampus: A Comprehensive Treatise. (Issacson, R. and Pribramm, K., eds.) Plenum, New York, pp. 285-322.
70. Mc Ewen B. S., Zigmond R. E., and Gerlach J. (1972) Sites of steroid binding and action in the brain, in Structure and Function of Nervous Tissue, vol. 5. (G.H. Bourne, ed.) Academic, New York. pp. 205-291.
71. Mecocci P. L., MacGarvey U., and Beal M. F. (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36, 747-750.
72. Miranda R. C. and Toran-Allerand C. D. (1992) Developmental expression of estrogen receptor mRNA in the rat cerebral cortex: a nonisotopic in situ hybridization histochemistry study. Cereb. Cortex 2, 1-15.
73. Miranda R., Sohrabji F., Singh M., and Toran-Allerand C. D. (1996) Nerve growth factor (NGF) regulation of estrogen receptors in explant cultures of the developing forebrain. J. Neurobiol. 31, 77-87.
74. Milward E. A., Papadopoulos R., Fuller S. J., Moir R. D., Small D., Beyreuther K., and Masters C. L. (1992) The amyloid precursor protein of AD is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 9, 129-137.
75. Milward E. A., Papadopoulos R., Fuller S. J., Moir R. D., Small D., Beyreuther K., and Masters C. L. (1992) The amyloid precursor protein of AD is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 9, 129-137.
76. Mosselman S., Polman J., Djikema R. (1996) ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett. 392, 49-53.
77. Mukai K., Daifuku K., and Yokoyama S. (1990) Stopped-flow investigation of antioxidant activity of estrogen in solution. Biochem. Biophys. Acta. 1035, 348-352.
78. Nakai M., Kawamata T., Taniguchi T., Maeda K., and Tanaka C. (1996) Expression of apolipoprotein E mRNA in rat microglia. Neurosci. Lett. 211, 41-44.
79. Namba Y., Tomonaga M., Kawasaki H., Otomo E., and Ikeda L. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease. Brain. Res. 541, 163-166.
80. Narita M., Bu G., Holtzman D. M., and Schwartz A. L. (1997) The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development. J. Neurochem. 68, 587-595.
81. Nathan B. P., Bellosta S., Sanan D. A., Weisgraber K. H., Mahley R. W., and Pitas R. E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850-852.
82. Newton C. J., Trapp T., and Pagotto U. (1994) The estrogen receptor modulates growth of pituitary tumor cells in the absence of exogenous estrogen. J. Mol. Endocrinol. 12, 303-312.
83. Pace P., Taylor J., Suntharalingam S., Coombes R. C., and Ali S. (1997) Human estrogen receptor β binds DNA in a manner similar to and dimerizes with estrogen receptor α. J. Biol. Chem. 272, 25,832-25,838.
84. Paganini-Hill A. and Henderson V. W. (1994) Estrogen deficiency increases the risk of Alzheimer's disease in women. Am. J. Epidemol. 140, 256-261.
85. Paganini-Hill A. and Henderson V. W. (1996) Estrogen replacement therapy and risk of Alzheimer disease. Arch. Intern. Med. 156, 2213-2217.
86. Parthasarathy S. S., Steinberg D., and Witztum J. L. (1992) The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Ann. Rev. Med. 43, 219-225.
87. Pitas R. E., Boyles J. K., Lee S. H., Foss D., and Mahley R. W. (1987) Lipoproteins and their receptors in the central nervous system-characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E (LDL) receptors in the brain. J. Biol. Chem. 262, 14,352-14,360.
88. Pitas R. E., Boyles J. K., Lee S. H., Foss D., and Mahley R. W. (1987) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta 917, 148-161.
89. Poirier J. (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17, 525-530.
90. Poirier J., Baccichet A., Dea D., and Gauthier S. (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodeling in hippocampus in adult rats. Neuroscience 55, 81-90.
91. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., and Gauthier S. (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342, 697-699.
92. Poirier J., Hess M., May P. C., and Finch C. E. (1991) Astrocytic apolipoprotein E mRNA and GPAP mRNA in hippocampus after etorhinal cortex lesioning. Mol. Brain Res. 11, 97-106.
93. Puttfarcken P. S., Manelli A. M., Falduto M. T., Getz G. S., and LaDu M. J. (1997) Effect of apolipoprotein E on neurite outgrowth and β-amyloid-induced toxicity in developing rat primary hippocampal cultures. J. Neurochem. 68, 760-769.
94. Rebeck G. W., Reiter J. S., Strickland D. K., and Hyman B. T. (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11, 575-580.
95. Rifici V. and Khachadurian A. K. (1992) The inhibition of low-density lipoprotein oxidation by 17-beta estradiol. Metabolism 41, 1110-1114.
96. Sacks F. M. and Walsh B. W. (1994) Sex hormones and lipoprotein metabolism. Curr. Opin. Lipidol. 5, 236-240.
97. Saitoh T., Sundsmo M., Rock J.-M., Kimura N., Cole G., Schubert D., Oltersdorf D., and Schenk D. B. (1989) Secreted form of amyloid-beta protein precursor is involved in the growth regulation of fibroblasts. Cell 58, 615-622.
98. Schmechel D. E., Saunders A. M., Strittmatter W. J., Crain B. J., Hulette C. M., Joo S. H., Pericak-Vance M. A., Goldgaber D., and Roses A. D. (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein e genotype in late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 9649-9653.
99. Schubert D., Jin L.-W., Saitoh T., and Cole G. (1991) The regulation of amyloid beta-protein precursor secretion and its modulatory role in cell adhesion. Neuron 3, 689-694.
100. Selkoe D. J. (1996) Amyloid-beta-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271, 18,295-18,298.
101. Selkoe D. J. (1994) Cell biology of the amyloid beta-protein precursors and the mechanism of Alzheimer's disease. Ann. Rev. Cell. Biol. 10, 373-403.
102. Seubert P., Oltersdorf T., Lee M. G., Barbour R., Blomguist C., Davis D. L., Bryant K., Fritz L. C., Galasco D., Thai L. J., Lieberburg I., and Schenk D. B. (1993) Secretion of β-amyloid precursor protein cleaved at the amino-terminus of the beta-amyloid peptide. Nature 361, 260-263.
103. Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Shaffer L. M., Cai X. D., McKay D. M., Tintner R., Frangione B., and Younkin S. G. (1992) Production of the Alzheimer amyloid beta protein by normal proteolitic processing. Science 258, 126-129.
104. Simpkins J. W., Singh M., and Bishop J. (1994) The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol. Aging. 15, S195-S197.
105. Smith C. D., Camey J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., and Markesbery W. R. (1991) Excess brain protein oxidation and enzyme disfunction in normal aging and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 88, 10,540-10,543.
106. Sohrabji F., Miranda R. C., and C. D. Toran-Allerand. (1995) Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 92, 11,110-11,114.
107. Soininen H. S. and Riekkinen P. J. Sr. (1996) Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci. 19, 224-228.
108. Soto C., Brañes M. C., Alvarez J., and Inestrosa N. C. (1994) Structural determinants of the Alzheimer's amyloid β-peptide. J. Neurochem. 63, 1191-1198.
109. Srivastava R. A., Bhasin N., and Srivastava N. (1996) Apolipoprotein E gene expression in various tissues of mouse and regulation by estrogen. Biochem. Mol. Biol. Int. 38, 91-101.
110. Stephenson J. (1996) More evidence links NSAID, estrogen use with reduced Alzheimer risk. JAMA. 275, 1389-1390.
111. Stone D. J., Rozovsky I., Morgan T. E., Anderson C. P., Hajian H., and Finch C. E. (1991) Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp. Neurol. 143, 313-318.
112. Subbarao K., Richardson J. S., and Ang L. C. (1990) Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55, 342-345.
113. Sugioka K., Shimosegawa Y., and Nakano M. (1987) Estrogen as natural antioxidant of membrane phospholipid peroxidation. FEBS Lett. 210, 37-39.
114. Tang M.-X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., and Mayeux R. (1996) Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348, 429-432.
115. Torand-Allerand C. D., Miranda R. C., Bentham W. D. L., Sohrabji F., Brown T. J., Hochberg R. B., and MacLusky N. J. (1992) Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc. Natl. Acad. Sci. USA 89, 4668-4672.
116. Van Harren F., Van Hest A., and Heinsbrock R. P. W. (1988) Behavioral differences between male and female rats: effects of gonadal hormones on learning and memory. Neurosci. Biobehav. Res. 14, 23-33.
117. Weisgraber K.H. (1994) Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45, 249-302.
118. Whitehouse P. J., Price D. L., Clark A. W., Coyle J. T., and DeLong M. R. (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10, 122-126.
119. Wieland N. G. (1992) Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CAI region of the hippocampus. Endocrinology 131, 662-667.
120. Williams C. L. and Meek W. H.(1991) The organizational effects of gonadal steroids on sexually dimorphic spatial ability. Psychoneuroendocrinology 16, 155-176.
121. Windler E. E., Kovanen P. J., Chao Y-S., Brown M. S., Havel R. J., and Goldstein J. L. (1980) The estradiol stimulated lipoprotein receptor of rat liver. J. Biol. Chem. 255, 10,464-10,471.
122. Yamada T., Kondo A., Takamatsu J., Tateishi J., and Goto I. (1995) Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease. J. Neurol. Sci. 129, 56-61.
123. Yankner B. A. (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
124. Zwain I. H., Yen S. S., and Cheng C. Y. (1997) Astrocytes cultured in vitro produce estradiol-17beta and express aromatase cytochrome P-450 (P-450 AROM) mRNA. Biochim. Biophys. Acta. 1334, 338-348.